loader image

- Advertisement -

USA
8,899,859
COVID-19 Active Cases
Updated on Mar 5, 2021 7:25 am
USA
533,641
COVID-19 Fatalities
Updated on Mar 5, 2021 7:25 am
Friday, March 5, 2021
69.9 F
McAllen
- Advertisement -

Publisher’s Word: Knapp Community Care Foundation Doing Great Philanthropic Work

2021 City of McAllen Mayoral Debate

The Rotary Clubs of McAllen will be conducting the first debate for the McAllen Mayoral race
- Advertisement -
- Advertisement -

Texas Border Business

Bonnie González is a professional woman well known in the community. She has always been at the top of leading entities in the Rio Grande Valley. Today, she is with Knapp Community Care Foundation, investing her passion into this foundation that funds nonprofit organizations that provide services for the Mid-Valley.

The foundation has eleven board members, and together with Bonnie, they strategize with a mission and vision to fund those organizations that help to prevent diabetes and obesity in the area of the Mid-Valley.

In this issue, get to know more about her and KCCF.

Good news: Two Coronavirus Vaccines enter Final Stages of Clinical Trials. According to Jonathan Weinberger, Executive Vice President, U.S. Chamber Global Innovation Policy Center wrote that as communities across the country consider whether to reopen schools and offices this fall, leaders are pinning their hopes to a COVID-19 vaccine that will soon be available.

Moderna began a Phase-3, 30,000-person trial for its leading vaccine candidate, developed in partnership with the National Institute of Allergy and Infectious Diseases. A day ahead of the beginning of the trial, the U.S. government threw additional support behind Moderna’s vaccine, committing an additional $472 million to the Phase 3 trial.

The story of these three innovative companies sheds light on the risk required to invest in innovative, life-saving treatments. To date, there has not yet been a successful mRNA vaccine developed. Should either the Moderna or Pfizer and BioNTech vaccine candidates prove successful, it would be an unprecedented breakthrough.

- Advertisement -

As these companies work at warp speed alongside other biopharmaceutical companies with vaccines in clinical development, the scientific community recognizes that an effective vaccine cannot come quickly enough. 

With our brightest scientific minds, the most innovative companies, and the nation’s leading universities on the task, the Chamber is confident that we will have an effective vaccine to help lead the global community out of this crisis soon. Let’s pray that they are successful in getting this vaccine.

Many other stories in this issue.


Stories mentioned on this article:

- Advertisement -
- Advertisement -
- Advertisement -

Latest News

More Articles Like This

- Advertisement -
×